Portrait of Mads Andersen, founder and CSO of IO Biotech

Professor Mads Hald Andersen, MD, Ph.D.

Founder, Scientific Advisor

Professor and Director of CCIT (Center for Cancer Immune Therapy at Herlev University Hospital. Mads Hald Andersen has received several honors for his scientific work and is the author of more than 130 papers. MHA has founded and co-founded several spin out companies with a successful sale of Survac in 2006.